{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:13:32Z","timestamp":1761513212542,"version":"build-2065373602"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.3816\/cbc.2005.s.003","type":"journal-article","created":{"date-parts":[[2008,9,12]],"date-time":"2008-09-12T21:20:47Z","timestamp":1221254447000},"page":"S41-S45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"S2","title":["Evaluating Bone Mass and Bone Quality in Patients with Breast Cancer"],"prefix":"10.3816","volume":"5","author":[{"given":"Alexander H.G.","family":"Paterson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.3816\/CBC.2005.s.003_bib1","series-title":"Tumor Bone Diseases and Osteoporosis in Cancer Patients: Pathophysiology, Diagnosis and Therapy","first-page":"1","article-title":"Basic principles of bone physiology","author":"Manolagas","year":"2000"},{"key":"10.3816\/CBC.2005.s.003_bib2","series-title":"Clinical Symposia No 4","article-title":"Osteoporosis: pathophysiology and prevention","author":"Kaplan","year":"1987"},{"key":"10.3816\/CBC.2005.s.003_bib3","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/8756-3282(94)90703-X","article-title":"Histomorphometric evidence for osteoclast mediated bone resorption in metastatic breast cancer","volume":"15","author":"Taube","year":"1994","journal-title":"Bone"},{"key":"10.3816\/CBC.2005.s.003_bib4","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/cncr.11127","article-title":"Bone markers in the management of patients with skeletal metastases","volume":"97","author":"Demers","year":"2003","journal-title":"Cancer"},{"key":"10.3816\/CBC.2005.s.003_bib5","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/cncr.11138","article-title":"A Phase 1 study of AMGN-0007, a recombinant osteoprotogerin construct, in patients with multiple myeloma or breast cancer related metastases","volume":"97","author":"Body","year":"2003","journal-title":"Cancer"},{"issue":"suppl 1","key":"10.3816\/CBC.2005.s.003_bib6","first-page":"S9","article-title":"Bone resorption and turnover in health and disease","volume":"8","author":"Mundy","year":"1987","journal-title":"Bone"},{"key":"10.3816\/CBC.2005.s.003_bib7","series-title":"Cancer and the Skeleton","first-page":"43","article-title":"Pathophysiology of bone metastases","author":"Mundy","year":"2000"},{"issue":"suppl","key":"10.3816\/CBC.2005.s.003_bib8","first-page":"1","article-title":"Cellular and molecular effects of growth hormone and estrogen on human bone cells","volume":"71","author":"Kassem","year":"1997","journal-title":"Acta Pathol Microbiol Immunol Scand"},{"key":"10.3816\/CBC.2005.s.003_bib9","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1200\/JCO.1997.15.3.955","article-title":"The bisphosphonate residronate prevents bone loss in women with artificial menopause due to chemotherapy of breast cancer: a double-blind, placebo-controlled study","volume":"15","author":"Delmas","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.3816\/CBC.2005.s.003_bib10","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/jnci\/90.9.704","article-title":"Oral clodronate and reduction in loss of bone mineral density in women with operable primary breast cancer","volume":"90","author":"Powles","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.3816\/CBC.2005.s.003_bib11","series-title":"Tumor Bone Diseases and Osteoporosis in Cancer Patients: Pathophysiology, Diagnosis and Therapy","first-page":"493","article-title":"Osteoporosis in patients with a history of breast cancer: causes and diagnosis","author":"Winding","year":"2000"},{"key":"10.3816\/CBC.2005.s.003_bib12","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/BF01321840","article-title":"Skeletal effects of withdrawal of estrogen and diphosphonate treatment in ovariectomised rats","volume":"53","author":"Wronski","year":"1993","journal-title":"Calcif Tissue Int"},{"key":"10.3816\/CBC.2005.s.003_bib13","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/sj.bjc.6690188","article-title":"A high incidence of vertebral fractures in women with breast cancer","volume":"79","author":"Kanis","year":"1999","journal-title":"Br J Cancer"},{"key":"10.3816\/CBC.2005.s.003_bib14","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1001\/jama.285.6.785","article-title":"Osteoporosis prevention, diagnosis, and therapy. NIH Consensus Development Conference Panel","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.3816\/CBC.2005.s.003_bib15","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s00198-003-1483-3","article-title":"The association between osteoporotic fractures and health-related quality of life as measured by the Health Utilities Index in the Canadian Multicentre Osteoporosis Study (CaMos)","volume":"14","author":"Adachi","year":"2003","journal-title":"Osteoporos Int"},{"key":"10.3816\/CBC.2005.s.003_bib16","first-page":"675","article-title":"Scientific Advisory Council of the Osteoporosis Society of Canada. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada","volume":"168","author":"Brown","year":"2003","journal-title":"CMAJ"},{"key":"10.3816\/CBC.2005.s.003_bib17","first-page":"518","article-title":"Prevention and treatment of osteoporosis. Clinical guidelines and new evidence","volume":"34","author":"Compston","year":"2000","journal-title":"J R Coll Physicians Lond"},{"key":"10.3816\/CBC.2005.s.003_bib18","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/BF01622200","article-title":"Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group","volume":"4","author":"Kanis","year":"1994","journal-title":"Osteoporos Int"},{"key":"10.3816\/CBC.2005.s.003_bib19","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1136\/bmj.315.7102.221","article-title":"Bone density and risk of hip fracture I in men and women: cross sectional analysis","volume":"315","author":"De Laet","year":"1997","journal-title":"BMJ"},{"key":"10.3816\/CBC.2005.s.003_bib20","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1001\/jama.285.3.320","article-title":"Risk of new vertebral fracture in the year following a fracture","volume":"285","author":"Lindsay","year":"2001","journal-title":"JAMA"},{"key":"10.3816\/CBC.2005.s.003_bib21","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1002\/cncr.10522","article-title":"The clinical use of bone resorption markers in patients with malignant bone disease","volume":"94","author":"Coleman","year":"2002","journal-title":"Cancer"},{"key":"10.3816\/CBC.2005.s.003_bib22","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/0140-6736(93)92935-M","article-title":"Mineralisation defects with pamidronate therapy for Paget's disease","volume":"342","author":"Adamson","year":"1993","journal-title":"Lancet"},{"key":"10.3816\/CBC.2005.s.003_bib23","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","article-title":"Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases","volume":"62","author":"Ruggiero","year":"2004","journal-title":"J Oral Maxillofac Surg"},{"key":"10.3816\/CBC.2005.s.003_bib24","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.bone.2003.11.006","article-title":"The steroidal aromatase inhibitor exemestane prevents bone loss in ovariectomized rats","volume":"34","author":"Goss","year":"2004","journal-title":"Bone"},{"key":"10.3816\/CBC.2005.s.003_bib25","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S8756-3282(00)00363-X","article-title":"Skeletal effects of estrogen deficiency as induced by an aromatase inhibitor in an aged male rat model","volume":"27","author":"Vanderschueren","year":"2000","journal-title":"Bone"},{"key":"10.3816\/CBC.2005.s.003_bib26","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1002\/cncr.11745","volume":"98","author":"Baum","year":"2003","journal-title":"Cancer"},{"key":"10.3816\/CBC.2005.s.003_bib27","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1056\/NEJMoa032312","article-title":"A randomised trial of letrozole in post-menopausal women after five years of tamoxifen therapy for early stage breast cancer","volume":"349","author":"Goss","year":"2003","journal-title":"N Engl J Med"},{"key":"10.3816\/CBC.2005.s.003_bib28","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1056\/NEJMoa040331","article-title":"A randomised trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer","volume":"350","author":"Coombes","year":"2004","journal-title":"N Engl J Med"},{"key":"10.3816\/CBC.2005.s.003_bib29","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0140-6736(04)17666-6","article-title":"Results of the ATAC trial after completion of 5 years' adjuvant treatment for breast cancer","volume":"365","author":"Howell","year":"2005","journal-title":"Lancet"},{"issue":"suppl 1","key":"10.3816\/CBC.2005.s.003_bib30","first-page":"S36","article-title":"Effect of letrozole versus placebo on bone mineral density in women completing \u22655 years (yrs) of adjuvant tamoxifen: ncic ctg ma.17b","volume":"88","author":"Perez","year":"2004","journal-title":"Breast Cancer Res Treat"},{"key":"10.3816\/CBC.2005.s.003_bib31","first-page":"6","article-title":"Effect of exemestane on bone: a randomized placebo controlled study in postmenopausal women with early breast cancer at low risk","volume":"23","author":"Lonning","year":"2004","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.3816\/CBC.2005.s.003_bib32","first-page":"614","article-title":"Effects of the aromatase inhibitor letrozole on normal breast epithelial cell proliferation and metabolic indices in postmenopausal women: a pilot study for breast cancer prevention","volume":"11","author":"Harper-Wynne","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.3816\/CBC.2005.s.003_bib33","first-page":"9","article-title":"Estrogens and bone metabolism in post menopausal women with early breast cancer at low risk treated with exemestane","volume":"23","author":"Geisler","year":"2004","journal-title":"Proc Am Soc Clin Oncol"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820911706929?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820911706929?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:10:01Z","timestamp":1761513001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820911706929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":33,"alternative-id":["S1526820911706929"],"URL":"https:\/\/doi.org\/10.3816\/cbc.2005.s.003","relation":{},"ISSN":["1526-8209"],"issn-type":[{"type":"print","value":"1526-8209"}],"subject":[],"published":{"date-parts":[[2005,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating Bone Mass and Bone Quality in Patients with Breast Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.3816\/CBC.2005.s.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}